In conclusion, GPR162 can be used as a novel tumor suppressor to promote the activation of STING in the DNA damage response induced by radiotherapy, and then activate STING to induce DNA damage of tumor cells, thus inhibiting the occurrence and development of tumors (Fig. 8g). The gene discussed is STING1; the disease is neoplasm.